Salvianolic acid B in vitro inhibited matrix metalloproteinases-1, -2, and-9 activities

Journal of Chinese Integrative Medicine

Volumn 7, Issue 2, 2009, Pages 145-150

  Liang, Ya Hui ^a   Li, Ping ^b   Huang, Qi Fu ^a   Zhao, Jingxia ^b   Liu, Xin ^b   Dai, Miao Ke ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Beijing Institute of Chinese Medicine   (China)

Author keywords

Matrix metalloproteinases rats; Salvia miltiorrhiza; Salviol

Indexed keywords

4 AMINOPHENYLMERCURIC ACETATE; GELATIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; SALVIANOLIC ACID B;

ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; IC 50; IN VITRO STUDY; MALE; NEUTROPHIL; NONHUMAN; RAT; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; BENZOFURANS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; RATS; RATS, WISTAR;

EID: 68949114627     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20090210     Document Type: Article

References (24)

1. Liu L, Zhang HQ. Advances in contemporary traditional Chinese medicine (TCM) pharmacology studies of active constituents of danshen (Salvia miltiorrhiza). Zhongguo Ye Sheng Zhi Wu Zi Yuan. 2003; 22(6): 1-4.
2. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. Invest Dermatol. 1993; 100(5): 721-725.
3. Xue M, Le NT, Jackson CJ. Targeting matrix metalloproteases to improve cutaneous wound healing. Expert Opin Ther Targets. 2006; 10(1): 143-155.
4. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999; 7(6): 442-452.
5. Ravanti L, Kähäri VM. Matrix metalloproteinases in wound repair. Int J Mol Med. 2000; 6(4): 391-407.
6. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil. 2005; 26(4): 306-319.
7. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg. 1993; 166(1): 74-81.
8. Nwomeh BC, Yager DR, Cohen IK. Physiology of the chronic wound. Clin Plast Surg. 1998; 25(3): 341-356.
9. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002; 45 (7): 1011-1016.
10. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix mctalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol. 1996; 107(5): 743-748.
11. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol. 1993; 101(1): 64-68.
12. Barone EJ, Yager DR, Pozez AL, Olutoye OO, Crossland MC, Diegelmann RF, Cohen IK. Interleukin-1α and collagenase activity elevated in chronic wounds. Plast Reconstr Surg. 1998; 102(4): 1023-1027.
13. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers, J Invest Dermatol. 1996; 106(5): 1119-1124.
14. Drinkwater SL, Smith A, Burnand KG. What can wound fluids tell us about the venous ulcer microenvironment? Int J Low Extrem Wounds. 2002; 1(3): 184-190.
15. Mwaura B, Mahendran B, Hynes N, Defreitas D, Avalos G, Adegbola T, Adham M, Connolly CE, Sultan S. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vasc Endovasc Surg. 2006; 31(3): 306-310.
16. Parks WC. Matrix metalloproteinases in repair. Wound Repair Reg. 1999; 7(6): 423-432.
17. Luo P, Chen XH, Sun RS, Ran XZ. Effects of Radix Salviae millitiorrhizae on the wound healing in rats with whole-body radiation injury. Zhongguo Lin Chuang Kang Fu. 2005; 9(6): 156-157.
18. Chen JC, Shi ZM, Zhou XF, Zhang CH, Liu G, Wang YN, Lu KB. Clinical and experimental studies of external application of Radix Salviae militiorrhizae in acceleration of wound healing. Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi. 1998; 4(4): 209-210. in English.
19. Wu HN, Sun H. Study on clinical therapeutic effect of composite Salvia Injection matched with Western medicine in treating diabetic foot. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003; 23(10): 727-729.
20. Que HF, Wang YF, Shen L, Wang YL, Tang HJ. Treatment of chronic skin ulcers with traditional Chinese medicine: a report of five cases. J Chin Integr Med. 2007; 5(2): 204-207.
21. Saariaho-Kere UK. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res. 1998; 290(Supplement 1): S47-S54.
22. Wall SJ, Sampson MJ, Levell N, Murphy G. Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts. Br J Dermatol. 2003; 149(1): 13-16.
23. Mirastschijski U, Impola U, Jahkola T, Karlsmark T, AGren MS, Saarialho-Kere U. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds. Hum Pathol. 2002; 33(3): 355-364.
24. Tao YY, Wang XL, Liu CH. Salvianolic acid-B effects on TGF-β1/ERK signaling transduction in NIH/3T3 fibroblast. Shou Du Yi Ke Da Xue Xue Bao. 2007; 28 (2): 192-195.